EP 42: Dr Hafiza Khan on Trust, Patient Outreach and Instagram

Average (ratings)

No ratings

•

Your rating

In one of her many posts on Instagram, we can see Dr Hafiza Khan holding a table summarising her reactogenicity after her second COVID shot. In the frame next to her is her son listing his own reactions.

Ankur’s guest is Dr Hafiza Khan, Cardiac Electrophysiologist at Baylor Scott & White Arrhythmia Management in Dallas. One of only 9 women in her field in Texas, she started to think about her legacy and the ways she can increase her impact and give back to her colleagues and patients as well as future medical students. 18 months ago, she started a microblog with the aim of drawing more women to her specialty and procedure-based medicine. Today she has more than 50.000 followers, many of them aspiring clinicians themselves. Her expertise and personal touch not only make her feed a great educational tool, but also a binge-worthy source at a time when building bridges between the scientific community and the public is key.
In this episode, Ankur asks Hafiza to talk about Instagram and reaching millennial and gen Z audiences, as well as the importance of developing and maintaining trust between different communities at a time of information overload.
Follow her on Instagram @heart.beat.doctor.

Questions and comments can be sent to “podcast@radciffe-group.com” and may be answered by Ankur in the next episode. Guest @HafizaKMD, hosted by @AnkurKalraMD. Produced by @RadcliffeCARDIO.

Read MoreRead Less

Episodes

Up Next

EP 43: Dr Nishtha Sodhi on Mentorship, Innovation and Inclusivity

EP43 • Mar 08, 2021 • 47m 20s

Dr Sodhi remembers the first time she stepped into a Cath lab and found her passion. Years later she was preparing to do a complex TAVR procedure with her colleagues when suddenly they all recognised the significance of four women coming together in the lab. The photo of the four of them was shared widely on social media. For Dr Sodhi it became a symbol of what great mentorship can achieve, and for many others it is a beacon of hope.
What drives Dr Nishtha Sodhi? What were the formative moments of Dr Sodhi’s career? What are the new frontiers of cardiology?

All Episodes

01: Conduction Abnormalities After TAVR/TAVI With Chad Kliger

EP01 • Apr 23, 2020 • 27m 44s

In our first episode, Ankur explains his vision for and inspiration to start ‘Parallax’, and speaks with Chad Kliger from Lenox Hill Hospital in New York about conduction abnormalities after transcatheter aortic valve replacement (TAVR/TAVI), a review article published in US Cardiology Review 13.1 Ankur and Chad look at conduction abnormalities after TAVR/TAVI with a focus on basic conduction system anatomy in relation to the aortic valve, the mechanism, incidence, predisposing factors for occurrence, impact on mortality and finally, proposed treatment algorithms for management. Hosted by @AnkurKalraMD. Produced by @RadcliffeCardiology.

... 5 6 7 8 9 10 11 12 13

... 11 12 13

Plant-Based Diet & Cardiovascular Health

06: Danielle Belardo @TheVeggieMD On A Whole-Food Plant-Based Diet And Cardiovascular Health

EP06 • Apr 23, 2020 • 34m 28s

In celebration of this month’s ‘National Eat Your Vegetables Day’, this week’s guest is @TheVeggieMD, one of the most prominent physicians on social media! Dr Danielle Belardo MD is a Cardiology Fellow, American Board of Internal Medicine certified and a member of the American College of Cardiology Nutrition and Lifestyle Sub-Committee.

In this episode, Ankur and Danielle speak about the evidence in favour of a whole-food plant-based diet to improve cardiovascular health, the ACC prevention guidelines, how to talk to patients about positive dietary change, the issue of lack of nutrition training in cardiovascular fellowships and what Danielle’s diet looks like as a busy whole-food plant-based cardiology fellow. On her own podcast ‘Nutrition Rounds’ Danielle has discussions about evidence-based plant-based nutrition with physicians who are leading experts in nutrition and health.

Hosted by @AnkurKalraMD. Produced by @RadcliffeCardiology.

Drug-Coated Balloons Small-Vessel CAD Brilakis - Megaly

05: Role Of Drug-Coated Balloons In Small-Vessel CAD With Emmanouil S Brilakis And Michael Megaly

EP05 • Apr 23, 2020 • 27m 43s

Listen to our first episode with two guests! Ankur spoke with Emmanouil S Brilakis, MD and Michael Megaly, MD from the Minneapolis Heart Institute, Abbott Northwestern Hospital about their article on the role of drug-coated balloons in small-vessel coronary artery disease (SVD) published in US Cardiology Review 13.1. Percutaneous coronary intervention of SVD remains challenging due to difficulties with device delivery and high restenosis rate, making drug-coated balloons an attractive emerging option in patients with SVD.

In this brilliant conversation, Ankur, Emmanouil and Michael unravel the potential advantages, challenges and practical realities of using drug-coated balloons in SVD, and the findings of the latest randomised controlled trials studying this area.

Hosted by @AnkurKalraMD. Produced by @RadcliffeCardiology. [Disclaimer: The use of drug-coated balloons in coronay intervention is still off-label; it has not been approved by the FDA.]

04: J Dawn Abbott On Recent Developments In Percutaneous Coronary Intervention

EP04 • Apr 23, 2020 • 34m 58s

We have observed a lot of developments in percutaneous coronary intervention (PCI) over the past 12 months with the publication of various studies and trials. This week, Ankur spoke with J. Dawn Abbott, MD, Associate Professor of Cardiology at Warren Medical School of Brown University about her recently published US Cardiology Review 13.1 article on the significant developments in PCI over the past 12 months.

Dawn is an associate editor of the journal Circulation: Cardiovascular Interventions and is widely known for her research program on PCI and peripheral arterial disease (PAD). Ankur and J. Dawn discuss multiple trials/studies that were published in 2018, including ORBITA, PIONEER-II and ABSORB. J. Dawn also shares her thoughts on the latest stent technologies.

Hosted by @AnkurKalraMD. Produced by @RadcliffeCardiology.

03: Athena Poppas on Effective Management of Hypertension

EP03 • Apr 23, 2020 • 29m 43s

This week’s podcast guest needs no introduction! Prof Athena Poppas is one of the most widely known cardiologists in the US and current Vice-President of the American College of Cardiology! Ankur spoke to Athena about her recently published US Cardiology Review 13.1 article on whether early management of hypertension by GPs can improve outcomes.

They discuss the importance of preventative medicine, their experience of reducing hypertension with non-pharmaceutical and pharmaceutical methods, and the significance of the integrated “team approach” when treating comorbid conditions such as hypertension. Athena also shares her thoughts on cardiologists’ responsibility to shape their patients’ lifestyle choices.

Hosted by @AnkurKalraMD. Produced by @RadcliffeCardiology.

02: Role Of High-Sensitivity Cardiac Troponin In ACS

EP02 • Apr 23, 2020 • 29m 55s

Ankur is back with his second #AudioArticle! This week he spoke with Santiago Garcia from the Minneapolis Heart Institute about Santiago’s US Cardiology Review 13.1 article on the role of high-sensitivity cardiac troponin (hscTn) assays and their ability to rapidly rule in or rule out acute coronary syndrome (ACS) with improved sensitivity.

Chest pain is one of the most common reasons for an emergency room visit in the US, with almost 6 million ER visits annually, yet there is no consensus on how to compare the results from various hscTn assays. Tune in to hear Santiago outline the advantages and limitations of using hscTn as a standard biomarket to evaluate patients with suspected ACS in the ER.

Hosted by @AnkurKalraMD. Produced by @RadcliffeCardiology.

... 20 21 22 23 24 25

... 23 24 25